Anti-tumor effects of metformin in animal models of hepatocellular carcinoma: a systematic review and meta-analysis.

作者: Juan Li , Pratika Y. Hernanda , Wichor M. Bramer , Maikel P. Peppelenbosch , Judith van Luijk

DOI: 10.1371/JOURNAL.PONE.0127967

关键词:

摘要: Background Several studies have reported that metformin can reduce the risk of hepatocellular carcinoma (HCC) in diabetes patients. However, direct anti-HCC effects hardly been studied patients, but extensively investigated animal models HCC. We therefore performed a systematic review and meta-analysis evaluating on

参考文章(28)
R. J. Shaw, M. Kosmatka, N. Bardeesy, R. L. Hurley, L. A. Witters, R. A. DePinho, L. C. Cantley, The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 3329- 3335 ,(2004) , 10.1073/PNAS.0308061100
Xianbin Cai, Xi Hu, Bozhi Cai, Qinjia Wang, Youfeng Li, Xiaojun Tan, Hui Hu, Xiaofeng Chen, Jiexiong Huang, Jidong Cheng, Xubin Jing, None, Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo Oncology Reports. ,vol. 30, pp. 2449- 2457 ,(2013) , 10.3892/OR.2013.2718
K. Tajima, A. Nakamura, J. Shirakawa, Y. Togashi, K. Orime, K. Sato, H. Inoue, M. Kaji, E. Sakamoto, Y. Ito, K. Aoki, Y. Nagashima, T. Atsumi, Y. Terauchi, Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. American Journal of Physiology-endocrinology and Metabolism. ,vol. 305, ,(2013) , 10.1152/AJPENDO.00133.2013
Longyi Zheng, Wen Yang, Fuquan Wu, Chao Wang, Lexing Yu, Liang Tang, Bijun Qiu, Yuqiong Li, Linna Guo, Mengchao Wu, Gensheng Feng, Dajin Zou, Hongyang Wang, Prognostic Significance of AMPK Activation and Therapeutic Effects of Metformin in Hepatocellular Carcinoma Clinical Cancer Research. ,vol. 19, pp. 5372- 5380 ,(2013) , 10.1158/1078-0432.CCR-13-0203
Jo-Heon Kim, Md. Morshedul Alam, Doek Bae Park, Moonjae Cho, Seung-Hong Lee, You-Jin Jeon, Dae-Yeul Yu, Tae Du Kim, Ha Young Kim, Chung Gu Cho, Dae Ho Lee, The Effect of Metformin Treatment on CRBP-I Level and Cancer Development in the Liver of HBx Transgenic Mice The Korean Journal of Physiology and Pharmacology. ,vol. 17, pp. 455- 461 ,(2013) , 10.4196/KJPP.2013.17.5.455
Yu Xiong, Qing-Jun Lu, Jing Zhao, Guo-Yang Wu, Metformin Inhibits Growth of Hepatocellular Carcinoma Cells by Inducing Apoptosis via Mitochondrion-Mediated Pathway Asian Pacific Journal of Cancer Prevention. ,vol. 13, pp. 3275- 3279 ,(2012) , 10.7314/APJCP.2012.13.7.3275
Gaochao Zhou, Robert Myers, Ying Li, Yuli Chen, Xiaolan Shen, Judy Fenyk-Melody, Margaret Wu, John Ventre, Thomas Doebber, Nobuharu Fujii, Nicolas Musi, Michael F. Hirshman, Laurie J. Goodyear, David E. Moller, Role of AMP-activated protein kinase in mechanism of metformin action Journal of Clinical Investigation. ,vol. 108, pp. 1167- 1174 ,(2001) , 10.1172/JCI13505
Kavita Bhalla, Bor Jang Hwang, Ruby E. Dewi, William Twaddel, Olga G. Goloubeva, Kwok-Kin Wong, Neeraj K. Saxena, Shyam Biswal, Geoffrey D. Girnun, Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis Cancer Prevention Research. ,vol. 5, pp. 544- 552 ,(2012) , 10.1158/1940-6207.CAPR-11-0228
Hsiao-Ping Chen, Jeng-Jer Shieh, Chia-Che Chang, Tzu-Ting Chen, Jaw-Town Lin, Ming-Shiang Wu, Jeng-Horng Lin, Chun-Ying Wu, Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies Gut. ,vol. 142, pp. 606- 615 ,(2012) , 10.1136/GUTJNL-2011-301708